BSEP inhibitors constitute a distinctive chemical class characterized by their unique capability to interact with the Bile Salt Export Pump (BSEP), an integral protein localized within the hepatocyte cell membrane. These compounds modulate the function of BSEP, a vital component of the hepatobiliary transport system responsible for the efflux of bile salts into the bile canaliculus. By engaging with BSEP, these inhibitors can disrupt its normal function, thereby influencing the hepatobiliary transport of bile salts.
The significance of BSEP inhibitors lies in their ability to shed light on the intricate mechanisms governing hepatobiliary transport and bile salt homeostasis. Researchers have been actively investigating the precise molecular interactions between BSEP and these inhibitors, aiming to unravel the underlying molecular intricacies. This endeavor has led to the identification of diverse chemical structures within the BSEP inhibitor class, each possessing distinct molecular attributes that contribute to their binding affinity and impact on BSEP-mediated transport processes. The exploration of BSEP inhibitors not only advances our understanding of hepatic physiology but also holds broader implications for the intricate network of pathways involved in bile salt regulation. As researchers delve deeper into the mechanistic insights of BSEP inhibitors, they provide valuable contributions to the intricate puzzle of hepatobiliary transport, yielding insights into the intricate coordination of bile salt dynamics within the physiological context.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Troglitazone | 97322-87-7 | sc-200904 sc-200904B sc-200904A | 5 mg 10 mg 25 mg | $110.00 $204.00 $435.00 | 9 | |
Interferes with BSEP function by altering membrane fluidity and disrupting its transport activity, potentially leading to cholestasis. | ||||||
Bosentan | 147536-97-8 | sc-210957 | 10 mg | $195.00 | 3 | |
Inhibits BSEP by directly interacting with the transporter, resulting in decreased bile acid transport and potential hepatotoxicity. | ||||||
Glyburide (Glibenclamide) | 10238-21-8 | sc-200982 sc-200982A sc-200982D sc-200982B sc-200982C | 1 g 5 g 25 g 100 g 500 g | $46.00 $61.00 $117.00 $173.00 $530.00 | 36 | |
Can inhibit BSEP function by modulating cellular signaling pathways or affecting membrane properties, contributing to bile acid retention. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Acts as a BSEP inhibitor by binding to the transporter and disrupting its function, potentially leading to liver injury. | ||||||
Fluvastatin | 93957-54-1 | sc-279169 | 50 mg | $250.00 | ||
May inhibit BSEP by altering membrane composition and affecting transporter function, potentially causing hepatobiliary adverse effects. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Inhibits BSEP by interfering with its function at the molecular level, which can lead to cholestasis and impaired bile acid secretion. | ||||||
Erythromycin | 114-07-8 | sc-204742 sc-204742A sc-204742B sc-204742C | 5 g 25 g 100 g 1 kg | $57.00 $245.00 $831.00 $1331.00 | 4 | |
Can inhibit BSEP by altering its function, potentially causing accumulation of bile acids and hepatotoxicity. | ||||||
Naringenin | 480-41-1 | sc-219338 | 25 g | $245.00 | 11 | |
Acts on BSEP by modulating cellular pathways or directly interacting with the transporter, potentially affecting bile acid transport. | ||||||
Tolvaptan | 150683-30-0 | sc-364638 sc-364638A | 10 mg 50 mg | $125.00 $624.00 | ||
May impact BSEP function through its effects on cellular processes, potentially leading to impaired bile acid secretion. | ||||||
Lopinavir | 192725-17-0 | sc-207831 | 10 mg | $132.00 | 6 | |
Inhibits BSEP function by directly interacting with the transporter, potentially causing hepatotoxicity and alterations in bile acid transport. | ||||||